Orthopaedic Practice Revenue Cycle Benchmarks 2026: How Your Group Compares (and Where the Money Leaks)

The orthopaedic practice revenue cycle benchmarks that matter most in 2026 are as follows:

- Clean claim rate above 95%

- First-pass denial rate below 5-8%

- Total accounts receivable (AR) under 35 days

- AR-over-90-days percentage below 15%, and a net collection rate above 96%

If your group of five or more surgeons is missing any of these targets, you are almost certainly leaving meaningful revenue uncollected, and the gap usually traces back to coding accuracy, denial workflows, and prior authorization timing rather than payer behavior alone. This guide breaks down each benchmark, explains what good looks like for an orthopaedic group specifically, and shows you where the most common leaks hide.

Orthopaedic groups are a different animal from primary care or general multispecialty practices. Surgical CPT coding is denser, modifier usage is heavier, prior authorization volume is higher, and a single mis-sequenced surgical claim can represent thousands of dollars rather than the tens or low hundreds at stake in an office visit. That is why generic revenue cycle benchmarks often understate the opportunity inside an ortho group. The numbers below are oriented toward what a high-performing orthopaedic practice should expect.

The Six Revenue Cycle Benchmarks Every Orthopaedic Practice Should Track

There are dozens of metrics a revenue cycle team can monitor, but six benchmarks tell you almost everything about the financial health of an orthopaedic group. Track these consistently and you will spot leaks before they compound across a quarter.

1. Clean Claim Rate (Target: 95%+)

Your clean claim rate is the percentage of claims accepted and adjudicated on first submission without edits, rejections, or rework. MGMA better-performing practices routinely report clean claim rates above 95%, and the best orthopaedic groups push toward 98%. Every point below that target represents claims that bounce back into a work queue, consuming staff time and delaying cash.

In orthopaedics, clean claim rate is overwhelmingly a coding and documentation problem rather than a data-entry problem. Missing or incorrect modifiers (think 25, 59, the X{EPSU} modifiers (XE, XP, XS, XU), 50, 51, RT and LT), mismatched diagnosis pointers, and surgical CPT codes that are not supported by the operative note are the leading culprits. If your clean claim rate is sitting at 88-92%, the fastest path to improvement is tightening the link between the clinical note and the codes submitted, not hiring more people to scrub claims after the fact.

2. First-Pass Denial Rate (Target: Below 5-8%)

Denial rate is the percentage of claims initially denied by payers. The American Academy of Family Physicians and industry RCM analyses generally cite a healthy first-pass denial rate in the 5-8% range (with under 5% considered strong), while many practices quietly tolerate rates of 10-15%. For orthopaedic groups, denials cluster around prior authorization failures, medical necessity documentation, and bundling or modifier issues on surgical claims.

The hidden cost is not just the denied dollars; it is the appeal labor. Industry estimates put the cost of reworking a single denied claim at roughly $25 to rework a single claim (MGMA), with industry estimates of the fully loaded cost per denied claim ranging higher, and a meaningful share of denied claims are never reworked at all. That abandoned revenue is pure leakage. A group running an 11% denial rate on high-value surgical claims is losing far more than the same rate would cost a primary care office.

3. Total AR Days (Target: Under 35 Days)

Days in accounts receivable measures how long, on average, it takes to collect payment after a service. MGMA benchmarks generally place strong performers under 35 days, with elite groups closer to 30. Orthopaedic AR can creep upward when surgical claims stall in prior authorization, when denials sit in an appeal queue, or when patient balances (increasingly large in high-deductible plans) age without a structured follow-up process.

4. AR Over 90 Days (Target: Below 15%)

Total AR days can look acceptable while a stubborn block of old claims hides underneath. That is why the percentage of AR aged beyond 90 days is a critical companion metric. Better-performing practices keep this below 15%, and elite performers target 12% or lower. A rising AR-over-90 figure in an orthopaedic group is frequently a denial and appeal backlog in disguise: the easy claims get paid quickly and pull the average down, while complex surgical denials languish past the 90-day mark where collection probability drops sharply.

5. Net Collection Rate (Target: 96%+)

Net collection rate measures how much of the legitimately collectible revenue you actually capture after contractual adjustments. A strong orthopaedic group should sit at 96% or above; falling below 95% signals systematic leakage from write-offs, missed timely-filing windows, undercoding, and abandoned denials. Net collection rate is the single best summary metric for revenue integrity because it captures everything that happens between the procedure and the deposit.

6. Charge Lag and Coding Turnaround (Target: Under 3-5 Days)

Charge lag is the time between a service being rendered and the charge being entered. The longer a surgical case sits uncoded, the closer it drifts to timely-filing deadlines and the longer cash is delayed. High-performing groups keep charge lag under three to five days. In practices where a single certified coder or a small team handles a heavy surgical volume, charge lag is often the first metric to deteriorate when someone goes on leave or turns over, which is exactly why coder dependency is a financial risk, not just a staffing one.

Where Orthopaedic Revenue Actually Leaks

When we map these benchmarks against real orthopaedic groups, the same three leaks appear over and over.

The first is undercoding. More than 20% of E&M cases are under-coded across the industry, and surgeons under-code their own surgical cases by more than 10% on average. This is the most invisible leak of all because nothing gets denied; the practice simply bills less than it earned and the money never shows up as a problem on any report. It only shows up as a lower revenue-per-surgeon number that leadership cannot easily explain.

The second is denials and abandoned appeals. With industry estimates of roughly $8 billion spent each year on denial appeals (per published RCM analyses), the labor cost of fighting denials is enormous, and the appeals that never get written represent silent losses. Orthopaedic surgical denials are high-dollar, so each abandoned appeal stings more.

The third is prior authorization breakdowns. More than 20% of orthopaedic cases need retro-authorization because the operative note and the final surgical CPT codes do not match what was originally authorized. If retro-authorization is not initiated quickly (ideally within 24 hours), those claims convert into denials and then into write-offs.

A Quick-Reference Benchmark Table for 2026

For leadership reviews, here is the at-a-glance scorecard a high-performing orthopaedic group should be measuring against:

- Clean claim rate: 95%+ (elite 98%)

- First-pass denial rate: under 5-8%

- Total AR days: under 35 (elite 30)

- AR over 90 days: under 15% (elite 12%)

- Net collection rate: 96%+

- Charge lag: under 3-5 days

- E&M undercoding: as close to 0% as possible (industry baseline is 20%+ undercoded)

If you run these numbers and find yourself outside the target on three or more, the issue is rarely your payers and rarely your people. It is almost always the system connecting your clinical documentation to your submitted claims.

How to Use These Benchmarks During Consolidation or Acquisition

For groups evaluating private-equity partnership or actively consolidating, revenue cycle benchmarks do double duty. They tell you how to run the practice, and they directly shape valuation. A buyer’s diligence team will look hard at net collection rate, denial rate, and AR aging because those numbers reveal how much normalized EBITDA is real versus how much is being lost to fixable process gaps. Closing a five-point denial-rate gap or recovering chronic undercoding before a transaction can move the valuation needle far more than the same operational improvement would move a single year’s distributions. The practices that present cleanly on these metrics negotiate from strength.

Frequently Asked Questions

Q: What is a good clean claim rate for an orthopaedic practice?

A: Aim for 95% or higher, with top-performing orthopaedic groups reaching 98%. Because surgical claims are high-dollar and modifier-heavy, even small clean-claim improvements translate into meaningful recovered cash and reduced rework.

Q: What denial rate should an orthopaedic group target?

A: A healthy first-pass denial rate is generally under 5%, and groups should treat anything consistently above 8-10% as a process problem. In orthopaedics, most denials stem from prior authorization mismatches, medical necessity documentation, and surgical bundling or modifier errors rather than from payers being unusually aggressive.

Q: How many AR days is too many for an orthopaedic practice?

A: Strong performers keep total AR under 35 days and AR over 90 days below 15%. If your AR-over-90 percentage is climbing while total AR days look fine, you likely have a backlog of high-value surgical denials aging in an appeal queue.

Q: How much revenue is the average orthopaedic practice losing to undercoding?

A: Industry data shows more than 20% of E&M cases are under-coded and surgeons under-code surgical cases by more than 10% on average. Because nothing gets denied, this leak is invisible on standard reports and usually surfaces only as an unexplained dip in revenue per surgeon.

Q: Where do these benchmarks come from?

A: They reflect widely cited MGMA better-performer ranges, CMS and industry denial-cost data, and AMA coding guidance. Treat them as directional targets and pair them with your own payer mix and specialty case-mix when setting internal goals.

The Fastest Way to Close the Gap

Every benchmark above shares a single upstream lever: the accuracy and speed of the link between your clinical documentation and your submitted codes. Tighten that link and clean claim rate rises, denials fall, AR ages less, undercoding disappears, and net collection rate climbs. That is precisely the layer Maia automates. Maia’s E&M and Surgical AutoCoder read the clinical and operative notes and recommend complete, compliant CPT, ICD-10, HCPCS, and modifier selections (with a confidence score) before a human coder touches the chart, while Prior Auth Reconciliation flags retro-authorization needs within 24 hours and AutoAppeal drafts denial appeals automatically. Groups like OrthoIndy, OrthoIllinois, Midwest Orthopaedics at Rush, the Bone and Joint Institute of Tennessee, and Health Plus Management rely on this orthopaedic-specific approach to protect revenue at the source.

See how Maia’s AutoCoder handles this automatically for orthopaedic practices. Book a demo today.

‍